최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Anais brasileiros de dermatología, v.85 no.3, 2010년, pp.324 - 330
Diogo, Hilda Conceição (Complexo Hospitalar Padre Bento de Guarulhos, Brasil) , Melhem, Márcia (Secretaria de Estado da Saú) , Sarpieri, Aldo (de de Sã) , Pires, Mario Cezar (o Paulo, Brasil)
BACKGROUND: Superficial and subcutaneous mycoses have a high prevalence and, often, chronic evolution. Therefore, they need extensive treatment with topic and/or systemic antifungal agents. Azoles and alilamines (terbinafine) are first-choice drugs to treat human and animal infections. Thus, evaluat...
Soares Z 201 2007 Dermatologia na pratica medica Micoses superficiais e profundas
Vera JRM Ventajas y desventajas de los antifungicos de uso topico
Brazilian J Microbiol. Soares MMSR 32 130 2001 In Vitro activity of antifungal and antiseptic agents against dermatophyte isolates from patients with tinea pedis
Enferm Infec Microbiol Clin. Mellado E 20 523 2002 10.1016/S0213-005X(02)72856-5 Importancia clinica de los mecanismos de resistencia de los hongos filamentosos a los antifungicos
Br Assoc Dermatol. Gupta AK 149 296 2003 10.1046/j.1365-2133.2003.05418.x In vitro susceptibility testing of ciclopirox, terbinafine, ketoconazole and itraconazole against dermatophytes and nondermatophytes, and in vitro evaluation of combination antifungal activity
Int J Dermatol. Jain S 39 412 2000 10.1046/j.1365-4362.2000.00978.x Terbinafine, a unique oral antifungal: current perceptions
Clin Experiment Dermatol. Jensen JC 14 110 1989 10.1111/j.1365-2230.1989.tb00904.x Clinical Pharmacokinetics of Terbinafine (Lamisil)
An Bras Dermatol. Almeida LMM 84 249 2009 10.1590/S0365-05962009000300006 Resposta in vitro de fungos agentes de micoses cutaneas frente aos antifungicos sistemicos mais utilizados na dermatologia
23 2004 Proposed Guideline - M. 44A
An Bras Dermatol. Diogo HC 80 591 2005 10.1590/S0365-05962005000700004 Preservacao de fungos em agua destilada
Diogo HC 155 2005
Lacaz CS 1998 Guia para Identificacao - Fungos - Actinomicetos - Algas De Interesse Medico
Laroni DH 20 1995 Medically Important Fungi - A guide to Identification 3rd
Rev Esp Quimioterap. Carrillo-Munoz AJ 17 244 2004 ¿Es activa la anfotericina B frente a hongos dermatofitos & Scopulariopis brevicaulis?
J Clin Microbiol. Rodriguez-Tudela JL 5236 2003 10.1128/JCM.41.11.5236-5237.2003 Interlaboratory Evaluation of Hemacytometer Method of Inoculum Preparation for Testing Antifungal Susceptibilities of Filamentous Fungi
Rodriguez-Tudela JL Unidad de Micologia Centro Nacional de Microbiologia Instituto De Salud Carlos III. Determinacion Minima Inhibitoria de Antifungicos frente a Hongos Filamentosos
J Clin Microbiol. Pfaller MA 49 77 2004 936 Clinical Isolates of Candida Species
J Clin Microbiol. Xu J 36 2383 1998 10.1128/JCM.36.8.2383-2385.1998 Colony size can be used to determine the MIC of fluconazole for pathogenic yeasts
22 2002 Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi: Approved Standard - M38-A
Barros MES 110 355 2006 In vitro methods for antifungal susceptibility testing of Trichophyton spp. J mycres
J Clin Microbiol. Meletiadis J 38 2949 2000 10.1128/JCM.38.8.2949-2954.2000 Comparison of NCCLS and 3-(4,5- Dimethyl-2Thiazyl)-2,5-Diphenyl-2H-Tetrazolium Bromide (MTT) Methods of In Vitro Susceptibility Testing of Filamentous Fungi and Development of a New Simplified Method
Antimicrob Agents Chemother. Serena C 48 2724 2004 10.1128/AAC.48.7.2724-2726.2004 In Vitro Antifungal Susceptibilities of Uncommon Basidiomycetous Yeasts
J Clin Microbiol. Santos DA 1917 2005 10.1128/JCM.43.4.1917-1920.2005 Evaluation of Broth Microdilution Antifungal Susceptibility Testing Conditions for Trichophyton rubrum
Rev Iberoam Micol. Cuenca-Estrela M 19 133 2002 Pueden basarse las indicaciones de los Antifungicos en los Estudios de Sensibilidad?
Antimicrob Agents Chemother. Ryder NS 42 1057 1998 10.1128/AAC.42.5.1057 In Vitro activities of Terbinafine against Cutaneous Isolates of Candida albicans end Other Pathogenic Yeasts
UEPG Ci Biol Saude. Esmerino LA 53 2004 Metodo Microbiologico para Determinacao da Potencia de Antimicrobianos
Rev Iberoam Micol Vivas JRC 18 113 2001 Sensibilidad de Hongos Miceliares Dematiaceos a Diez Antifungicos Empleando um Metodo de Difusion em Agar
0933-7407 Mycoses Speeleveld E 39 37 1996 10.1111/j.1439-0507.1996.tb00081.x Susceptibility of Clinical of Fusarium to antifungal drugs
J Antimicrob Chemother. Garcia-Effron G 53 1086 2004 10.1093/jac/dkh228 In vitro activity of terbinafine against medically important nondermatophyte species of filamentous fungi
J Vet Pharmacacol Therap. Bossche HV 26 5 2003 10.1046/j.1365-2885.2003.00456.x Antifungal agents of use in animal health - chemical, biochemical and pharmacological aspects
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.